Senior HEOR Expert – Rare Disease, Global Access

UCB

Slough

Hybrid

GBP 90,000 - 130,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

UCB is seeking a Health Economics & Outcomes Research Senior Expert to shape evidence generation for payer and HTA teams across global markets. The role spans asset value assessments, economic models, and publications to support patient access for rare diseases.

You will collaborate with HEOR, Market Access, Medical Affairs, and Real World Evidence teams, influencing development programs and global value dossiers while advancing HTA readiness and reimbursement strategies.

Qualifications

  • Master's degree or PhD in Health Economics, Outcomes Research, Market Access, Public Health, Epidemiology, Pharmacy, or a related discipline.
  • Strong experience within HEOR, Market Access, Outcomes Research, or Health Economics in the pharmaceutical, biotechnology, or consulting sectors.
  • Expertise in health economic modelling, cost-effectiveness analyses, budget impact modelling, and outcomes research methodologies.
  • Experience supporting HTA submissions, reimbursement processes, and payer evidence requirements across multiple markets.
  • Rare Disease experience is highly desirable.
  • Experience working across regions or at a global/intercontinental level, with a strong understanding of diverse healthcare systems and payer environments.

Responsibilities

  • Support the development and execution of global HEOR and payer evidence strategies aligned with asset and market access objectives.
  • Design and deliver HEOR studies and deliverables, including cost-effectiveness models, budget impact models, systematic literature reviews, indirect treatment comparisons, HCRU studies, and HRQoL research.
  • Develop asset value assessments and economic value frameworks to support pricing, reimbursement, and access decisions.
  • Shape and communicate compelling economic value stories for assigned assets and indications.
  • Influence clinical development programs to ensure evidence generation plans address HTA and payer requirements, including evolving EU HTA needs.
  • Contribute to global value dossiers and support affiliates in the development of robust market access and reimbursement strategies.
  • Partner with cross-functional teams to deliver evidence generation initiatives such as patient preference studies, natural history studies, and other outcomes research programs.
  • Provide HEOR expertise and guidance throughout the product lifecycle, helping translate evidence into successful access outcomes.
  • Contribute to scientific publications, congress presentations, abstracts, posters, and external scientific engagement activities.
  • Support innovation and continuous improvement by sharing best practices, methodologies, and emerging approaches across the HEOR community.

Skills

HEOR
Market Access
Outcomes Research
Health Economics

Education

Master's or PhD in Health Economics or related field

Job description

UCB is seeking a Health Economics & Outcomes Research Senior Expert to shape evidence generation for payer and HTA teams across global markets. The role spans asset value assessments, economic models, and publications to support patient access for rare diseases.

You will collaborate with HEOR, Market Access, Medical Affairs, and Real World Evidence teams, influencing development programs and global value dossiers while advancing HTA readiness and reimbursement strategies.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global HEOR Strategy Lead: Payer Evidence & Access
Global HEOR Strategy Lead: Payer Evidence & Access

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Health Economics & Outcomes Research Senior Expert - Rare Disease (UK)
Health Economics & Outcomes Research Senior Expert - Rare Disease (UK)

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Global HEOR Strategy Lead, Payer & Value Insights
Global HEOR Strategy Lead, Payer & Value Insights

UCB S.A. • Slough

Hybrid
GBP 90,000 - 130,000
Hybrid work model
Global exposure
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB S.A. • Slough

Hybrid
GBP 90,000 - 130,000
Hybrid work model
Global exposure
Director, Global HEOR & Payer Access
Director, Global HEOR & Payer Access

Ipsen • England

Hybrid
GBP 90,000 - 140,000
Access & Pricing Strategy Lead - Neurology (United Kingdom)
Access & Pricing Strategy Lead - Neurology (United Kingdom)

UCB • Slough

Hybrid
GBP 120,000 - 150,000
RWE Strategy Lead, Developed Brands (UK)
RWE Strategy Lead, Developed Brands (UK)

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Global HEOR & Value Strategy Director
Global HEOR & Value Strategy Director

Jazz Pharmaceuticals, Inc. • Cambridge

On-site
GBP 160,000 - 241,000
Medical, dental and vision insurance
401k retirement plan
Flexible paid vacation
Access & Pricing Strategy Team Lead - Neurology (United Kingdom)
Access & Pricing Strategy Team Lead - Neurology (United Kingdom)

UCB • Slough

Hybrid
GBP 90,000 - 130,000